Go Pro
OTCMKTS:CVALF

Covalon Technologies Q4 2024 Earnings Report

Covalon Technologies logo
$2.95 -0.25 (-7.70%)
As of 09/29/2026 02:45 PM Eastern

Covalon Technologies EPS Results

Actual EPS
$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Covalon Technologies Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Covalon Technologies Announcement Details

Quarter
Q4 2024
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Covalon Technologies' next earnings date is estimated for Thursday, December 10, 2026, based on past reporting schedules.

Conference Call Resources

Covalon Technologies Earnings Headlines

Covalon Reports Fiscal 2026 Third Quarter Results
Covalon Technologies Ltd CVALF
A “bloodbath” Is Coming
Reports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the country entirely - as concerns grow about the next phase of the AI market. One AI insider says investors should reassess their positions before September 30, pointing to a critical shift ahead for tech and AI-related stocks.tc pixel
Covalon Reports 2026 Second Quarter Results
See More Covalon Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Covalon Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Covalon Technologies and other key companies, straight to your email.

About Covalon Technologies

Covalon Technologies (OTCMKTS:CVALF) is a Canadian medical technology company focused on developing and commercializing advanced healthcare products. Its activities center on wound care, infection prevention and surgical applications, with technologies designed to help protect tissue, support healing and improve the management of medical procedures.

The company’s product portfolio includes collagen-based wound care products marketed under the ColActive brand, as well as antimicrobial and protective coatings, dressings and other medical devices. Covalon develops technologies for use in hospitals, clinics and other healthcare settings, including products intended to address chronic wounds, surgical wounds and infection-control needs.

Covalon serves healthcare providers and patients through commercial relationships with distributors and medical organizations in North America and selected international markets. The company is headquartered in Canada and has historically operated as a publicly traded healthcare technology business under the Covalon name.

View Covalon Technologies Profile